Related Experiment Video
Updated: May 15, 2026
05:06
Mechanical Dissociation of Tissues for Single Cell Analysis Using a Motorized Device
Published on: November 10, 2023
[Development trend of nanomedicines]
1Division of Drugs, National Institute of Health Sciences, Tokyo, Japan. kumikato@nihs.go.jp
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|January 8, 2013
Summary
Nanomedicine regulation is evolving globally, focusing on defining nanomedicines and evaluating nanoparticles like liposomes and iron nanoparticles for disease diagnosis and treatment.
Area of Science:
- Nanomedicine
- Regulatory Science
- Materials Science
Context:
- Nanotechnology's societal impact since 2000.
- Advancements in nanomedicine for disease diagnosis, treatment, and prevention.
- Growing need for standardized regulatory frameworks.
Purpose:
- To review international trends in nanomedicine regulation.
- To define nanomedicines within regulatory contexts.
- To outline evaluation methods for key nanomedicine components.
Summary:
- Discusses the global regulatory landscape for nanomedicines.
- Covers the definition and classification of nanomedicines.
- Examines regulatory considerations for liposomes and iron nanoparticles.
Impact:
- Informs regulatory bodies and researchers on nanomedicine governance.
- Facilitates the safe and effective translation of nanomedicines.
- Supports the development of global standards for nanomedicine evaluation.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...